30.20
+1.40
+(4.86%)
At close: January 16 at 10:15:01 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
34,767.00
34,767.00
29,145.00
30,513.00
25,960.00
Cost of Revenue
13,391.00
13,391.00
12,475.00
12,927.00
10,176.00
Gross Profit
21,376.00
21,376.00
16,670.00
17,586.00
15,784.00
Operating Expense
20,746.00
20,746.00
16,567.00
14,035.00
13,613.00
Operating Income
630.00
630.00
103.00
3,551.00
2,171.00
Net Non Operating Interest Income Expense
30.00
30.00
-276.00
-267.00
-60.00
Pretax Income
797.00
797.00
875.00
2,683.00
1,141.00
Tax Provision
414.00
414.00
288.00
499.00
257.00
Net Income Common Stockholders
383.00
383.00
587.00
2,184.00
884.00
Diluted NI Available to Com Stockholders
383.00
383.00
587.00
2,184.00
884.00
Basic EPS
0.00
--
0.01
0.02
0.01
Diluted EPS
0.00
--
0.01
0.02
0.01
Basic Average Shares
139,078.31
--
135,407.25
139,760.21
140,608.28
Diluted Average Shares
139,078.31
--
135,407.25
139,760.21
140,608.28
Total Operating Income as Reported
766.00
766.00
1,151.00
2,950.00
1,201.00
Total Expenses
34,137.00
34,137.00
29,042.00
26,962.00
23,789.00
Net Income from Continuing & Discontinued Operation
383.00
383.00
587.00
2,184.00
884.00
Normalized Income
383.00
383.00
587.00
2,193.77
884.00
Interest Income
443.00
443.00
28.00
21.00
44.00
Interest Expense
311.00
311.00
236.00
232.00
46.00
Net Interest Income
30.00
30.00
-276.00
-267.00
-60.00
EBIT
1,108.00
1,108.00
1,111.00
2,915.00
1,187.00
EBITDA
2,926.00
2,926.00
2,606.00
4,391.00
2,415.00
Reconciled Cost of Revenue
13,391.00
13,391.00
12,475.00
12,927.00
10,176.00
Reconciled Depreciation
1,818.00
1,818.00
1,495.00
1,476.00
1,228.00
Net Income from Continuing Operation Net Minority Interest
383.00
383.00
587.00
2,184.00
884.00
Total Unusual Items Excluding Goodwill
--
--
--
-12.00
--
Total Unusual Items
--
--
--
-12.00
--
Normalized EBITDA
2,926.00
2,926.00
2,606.00
4,403.00
2,415.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
--
-2.23
--
12/31/2020 - 3/12/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IOB.DU Ion Beam Applications SA
12.98
-2.41%
8C4.F CYBERDYNE Inc.
1.0440
-0.19%
2SE.F Sequana Medical NV
2.5400
-1.17%
CYBQF CYBERDYNE Inc.
1.0350
0.00%
NEOLA.ST Neola Medical AB (publ)
2.5400
-0.78%
ABT.VI Abbott Laboratories
110.40
+0.84%
2SE.SG Sequana Medical NV
2.5400
-2.68%
EPIS-B.ST Episurf Medical AB (publ)
0.1318
-2.23%
P09.SG Pacific Biosciences of California Inc
1.5986
+2.46%
ABL.SG Abbott Laboratories
110.38
+0.44%